Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas [SBIR (R43/R44)]
The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
12/17/2012
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
RFA-DK-13-001
Opportunity Category:
Discretionary
Posted Date:
Dec 17, 2012
Creation Date:
Dec 17, 2012
Original Closing Date for Applications:
Mar 06, 2013
Current Closing Date for Applications:
Mar 06, 2013
Archive Date:
Apr 06, 2013
Funding Instrument Type:
Grant
Category of Funding Activity:
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
$2,500,000
Award Ceiling:
Award Floor:
CFDA Number(s):
93.286
--
Discovery and Applied Research for Technological Innovations to Improve Human Health
93.847
--
Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Small businesses
Additional Information on Eligibility:
Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Agency Name
National Institutes of Health
Description
This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress toward integrated long term glucose regulated insulin/pancreatic hormones delivery systems (artificial pancreas).
